Private company
Sofinnova Partners SAS
Last updated Oct 21, 2026.
Overview
- HeadquartersI01
Corporate structure
Sofinnova Partners SAS is part of a group headed by Société Civile Montclair. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Sofinnova Partners SAS
- Apo Nova Holdings L.P. Owns 10% to 25% of Sofinnova Partners SAS, since 08/2022 (Form ADV)
- Société Civile Montclair
- Sofinnova Partners SAS I0
- IRulya Therapeutics Inc. Stake · New Haven, Connecticut
- Sofinnova Partners SAS I0
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies); owners and owned firms from Form ADV, the registration investment advisers file with the SEC. Each entity in the chart links to its source.
Investment adviser
Sofinnova Partners SAS is registered with the SEC as an investment adviser. This is what it reports on Form ADV, the registration every adviser files and keeps current.
- RegistrationSEC 802-76686, CRD 164104 IAPD record
Who owns it
Owners of 5% or more as the firm lists them (Schedule A), and the owners of those owners up the chain (Schedule B).
- SOCIÉTÉ CIVILE MONTCLAIRowns 75% or more, since 04/2012
- APO NOVA HOLDINGS L.P.owns 10% to 25%, since 08/2022
Stakes it holds
Sofinnova Partners SAS has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).
- IRulya Therapeutics Inc.SCHEDULE 13G/A Feb 12, 2024 to Apr 30, 20253
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3